Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions

NCT07371182 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis (LCH)

Interventions

DRUG: Luvometinib

Sponsor

West China Second University Hospital